JP2017215338A5 - - Google Patents

Download PDF

Info

Publication number
JP2017215338A5
JP2017215338A5 JP2017149809A JP2017149809A JP2017215338A5 JP 2017215338 A5 JP2017215338 A5 JP 2017215338A5 JP 2017149809 A JP2017149809 A JP 2017149809A JP 2017149809 A JP2017149809 A JP 2017149809A JP 2017215338 A5 JP2017215338 A5 JP 2017215338A5
Authority
JP
Japan
Prior art keywords
histone
body fluid
isoform
fluid sample
nucleosome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017149809A
Other languages
English (en)
Japanese (ja)
Other versions
JP6494703B2 (ja
JP2017215338A (ja
Filing date
Publication date
Priority claimed from GBGB1115098.4A external-priority patent/GB201115098D0/en
Application filed filed Critical
Publication of JP2017215338A publication Critical patent/JP2017215338A/ja
Publication of JP2017215338A5 publication Critical patent/JP2017215338A5/ja
Application granted granted Critical
Publication of JP6494703B2 publication Critical patent/JP6494703B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017149809A 2011-09-01 2017-08-02 ヒストン変種含有ヌクレオソーム検出法 Active JP6494703B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161530304P 2011-09-01 2011-09-01
GB1115098.4 2011-09-01
US61/530,304 2011-09-01
GBGB1115098.4A GB201115098D0 (en) 2011-09-01 2011-09-01 Method for detecting nucleosomes containing histone variants

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2014527738A Division JP2014529405A (ja) 2011-09-01 2012-08-31 ヒストン変種含有ヌクレオソーム検出法

Publications (3)

Publication Number Publication Date
JP2017215338A JP2017215338A (ja) 2017-12-07
JP2017215338A5 true JP2017215338A5 (cg-RX-API-DMAC7.html) 2018-02-22
JP6494703B2 JP6494703B2 (ja) 2019-04-03

Family

ID=44882049

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014527738A Withdrawn JP2014529405A (ja) 2011-09-01 2012-08-31 ヒストン変種含有ヌクレオソーム検出法
JP2017149809A Active JP6494703B2 (ja) 2011-09-01 2017-08-02 ヒストン変種含有ヌクレオソーム検出法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2014527738A Withdrawn JP2014529405A (ja) 2011-09-01 2012-08-31 ヒストン変種含有ヌクレオソーム検出法

Country Status (20)

Country Link
US (5) US9400276B2 (cg-RX-API-DMAC7.html)
EP (2) EP2751569B1 (cg-RX-API-DMAC7.html)
JP (2) JP2014529405A (cg-RX-API-DMAC7.html)
KR (1) KR102130855B1 (cg-RX-API-DMAC7.html)
CN (2) CN108107215A (cg-RX-API-DMAC7.html)
AU (1) AU2012300643B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014004584B1 (cg-RX-API-DMAC7.html)
CA (1) CA2845994C (cg-RX-API-DMAC7.html)
DK (1) DK2751569T3 (cg-RX-API-DMAC7.html)
ES (2) ES2955475T3 (cg-RX-API-DMAC7.html)
GB (1) GB201115098D0 (cg-RX-API-DMAC7.html)
HR (1) HRP20180362T1 (cg-RX-API-DMAC7.html)
HU (1) HUE038517T2 (cg-RX-API-DMAC7.html)
MX (1) MX349561B (cg-RX-API-DMAC7.html)
PL (1) PL2751569T3 (cg-RX-API-DMAC7.html)
PT (1) PT2751569T (cg-RX-API-DMAC7.html)
RU (2) RU2014112348A (cg-RX-API-DMAC7.html)
SG (2) SG10201601168QA (cg-RX-API-DMAC7.html)
WO (1) WO2013030579A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201401296B (cg-RX-API-DMAC7.html)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201115095D0 (en) * 2011-09-01 2011-10-19 Singapore Volition Pte Ltd Method for detecting nucleosomes containing nucleotides
GB201115098D0 (en) 2011-09-01 2011-10-19 Belgian Volition Sa Method for detecting nucleosomes containing histone variants
US9605313B2 (en) 2012-03-02 2017-03-28 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
WO2013184930A2 (en) 2012-06-06 2013-12-12 Trustees Of Princeton University Dna barcoding of designer mononucleosome and chromatin array libraries for the profiling of chromatin readers, writers, erasers, and modulators thereof
EP3597774A1 (en) 2013-03-13 2020-01-22 Sequenom, Inc. Primers for dna methylation analysis
WO2015138774A1 (en) 2014-03-13 2015-09-17 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
EP3213084B2 (en) 2014-10-29 2023-12-13 Belgian Volition SPRL Method for the enrichment of circulating tumor dna
CN107250799B (zh) * 2015-02-10 2019-09-10 B.R.A.H.M.S 有限公司 作为生物标志物的游离组蛋白
GB201511512D0 (en) * 2015-07-01 2015-08-12 Singapore Volition Pte Ltd Use of cell-free nucleosomes as biomarkers
GB201511542D0 (en) * 2015-07-01 2015-08-12 Singapore Volition Pte Ltd Use of cell free nucleosomes as biomarkers
GB201518674D0 (en) 2015-10-21 2015-12-02 Singapore Volition Pte Ltd Method for detecting nuleosomes containing histone modifications and variants
GB201518665D0 (en) * 2015-10-21 2015-12-02 Singapore Volition Pte Ltd Method for enrichment of cell free nucleosomes
GB201604806D0 (en) * 2016-03-22 2016-05-04 Singapore Volition Pte Ltd Method of identifying a cancer of unknown origin
GB201612815D0 (en) * 2016-07-25 2016-09-07 Belgian Volition Sa Novel combination test
TWI726009B (zh) * 2016-11-28 2021-05-01 比利時商比利時意志有限公司 用親和純化法分析生物樣品中源自腫瘤之無細胞核小體、分離生物樣品中純化之腫瘤dna、檢測生物樣品中源自腫瘤之核小體表觀遺傳表位或在動物或人類受試者中檢測癌症之方法或包括組蛋白h1結合劑之套組之用途
AU2017371324B2 (en) 2016-12-09 2024-06-13 Massachusetts Institute Of Technology CRISPR effector system based diagnostics
KR20190140918A (ko) 2017-03-15 2019-12-20 더 브로드 인스티튜트, 인코퍼레이티드 바이러스 검출을 위한 crispr 이펙터 시스템 기반 진단
GB201721569D0 (en) 2017-12-21 2018-02-07 Belgian Volition Sprl Method for the detection and treatment of colorectal adenomas
FI3746568T3 (fi) 2018-01-29 2023-12-12 Broad Inst Inc Crispr-efektorijärjestelmään perustuva diagnostiikka
CA3091807A1 (en) * 2018-03-01 2019-09-06 Epicypher, Inc. Quantification of nucleosome modifications using chemically-defined recombinant nucleosomes
GB2587939B (en) 2018-04-02 2023-06-14 Grail Llc Methylation markers and targeted methylation probe panels
CN113286881A (zh) 2018-09-27 2021-08-20 格里尔公司 甲基化标记和标靶甲基化探针板
GB201818965D0 (en) 2018-11-21 2019-01-09 Belgian Volition Sprl Method for the detection of colorectal cancer
GB201818963D0 (en) 2018-11-21 2019-01-09 Belgian Volition Sprl Methof for the detection of prostate cancer
GB201906199D0 (en) 2019-05-02 2019-06-19 Belgian Volition Sprl Method for the detection of cancer
GB201906201D0 (en) 2019-05-02 2019-06-19 Belgian Voltion Sprl Method for the detection of protate cancer
GB201912251D0 (en) 2019-08-27 2019-10-09 Belgian Volition Sprl Method of isolating circulating nucleosomes
CN114901832A (zh) 2019-08-27 2022-08-12 比利时意志有限责任公司 分离循环核小体的方法
EP4435431A3 (en) 2019-12-02 2024-10-16 Belgian Volition SRL Use of cell free nucleosomes as biomarkers
MX2022011614A (es) 2020-03-20 2022-10-13 Belgian Volition Srl Metodo de triaje utilizando niveles de nucleosomas libres de celulas.
WO2022058604A1 (en) 2020-09-21 2022-03-24 Belgian Volition Srl Device for inline monitoring of free nucleosomes in blood
TW202238131A (zh) 2020-11-25 2022-10-01 比利時商比利時意志有限公司 測量無細胞核蛋白染色質片段之方法
TW202238132A (zh) 2020-12-08 2022-10-01 比利時商比利時意志有限公司 多發性硬化症之診斷方法
TW202242130A (zh) 2020-12-29 2022-11-01 比利時商比利時意志有限公司 循環轉錄因子分析
TW202242145A (zh) 2020-12-29 2022-11-01 比利時商比利時意志有限公司 核小體耗盡循環無細胞染色質片段之轉錄因子結合位點分析
TW202242146A (zh) 2021-01-13 2022-11-01 比利時商比利時意志有限公司 肺癌的檢測方法
GB202108185D0 (en) 2021-06-08 2021-07-21 Belgian Volition Sprl Standardisation of nucleosome assays using biologically derived calibrants
GB202108452D0 (en) 2021-06-14 2021-07-28 Belgian Volition Sprl Triaging method using cell free nucleosome levels
JP2024542996A (ja) 2021-10-29 2024-11-19 ベルジアン ボリション エスアールエル 均一系免疫アッセイ法
GB202117799D0 (en) 2021-12-09 2022-01-26 Belgian Volition Srl Method for the detection of blood cancer
WO2023170298A1 (en) 2022-03-11 2023-09-14 Belgian Volition Srl Differential diagnosis method
GB202205212D0 (en) 2022-04-08 2022-05-25 Belgian Volition Sprl Method for transplant organ health assessment
WO2024042210A1 (en) 2022-08-25 2024-02-29 Belgian Volition Srl Method for measuring cell free chromatin
EP4577835A1 (en) 2022-08-25 2025-07-02 Belgian Volition SRL Method for the detection of dementia
WO2024133225A1 (en) 2022-12-19 2024-06-27 Belgian Volition Srl Calibration
EP4639165A1 (en) 2022-12-19 2025-10-29 Belgian Volition SRL Assessment of biological samples for nucleic acid analysis
GB202300607D0 (en) 2023-01-16 2023-03-01 Belgian Volition Srl Proteins and methods for isolating circulating nucleosomes
GB202303562D0 (en) 2023-03-10 2023-04-26 Belgian Volition Sprl Sample collection for liquid biopsy
WO2024213795A1 (en) 2023-04-14 2024-10-17 Belgian Volition Srl Diagnosis method using cell free nucleosome levels
WO2024223947A1 (en) 2023-04-28 2024-10-31 Belgian Volition Srl Use of cell free nucleosomes as biomarkers of carcinomas
GB202307768D0 (en) 2023-05-24 2023-07-05 Belgian Volition Srl Use of cell free nucleosomes as biomarkers
GB202310137D0 (en) 2023-07-03 2023-08-16 Belgian Volition Srl Method for the detection of cancer
WO2025012440A1 (en) 2023-07-13 2025-01-16 Belgian Volition Srl Method for detection of the potential of a body fluid sample to produce extracellular traps
WO2025061853A1 (en) 2023-09-19 2025-03-27 Belgian Volition Srl Lateral flow test device
WO2025093747A1 (en) 2023-11-02 2025-05-08 Belgian Volition Srl Novel rapid high-throughput method of netosis induction and inhibition with physiologically relevant molecules
WO2025181348A1 (en) 2024-03-01 2025-09-04 Belgian Volition Srl Method for determining the origin of circulating dna
WO2025253002A1 (en) 2024-06-07 2025-12-11 Belgian Volition Srl Sample collection for liquid biopsy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040186274A1 (en) 2001-07-03 2004-09-23 Allis C. David Methylation of histone h4 at arginine 3
DE10207735A1 (de) * 2002-02-15 2003-08-28 Euroimmun Gmbh Verfahren zur Herstellung einer Nukleosomen-Präparation und deren Verwendung zur in vitro-Diagnose von Lupus erythematodes disseminatus (LED)
AU2003216291A1 (en) 2002-02-20 2003-09-09 Chroma Therapeutics Ltd. A non-invasive diagnostic test utilizing histone modification markers
GB0319376D0 (en) * 2003-08-18 2003-09-17 Chroma Therapeutics Ltd Histone modification detection
WO2005040814A1 (en) * 2003-10-14 2005-05-06 Cancer Research Technology Limited Methods and means of cancer detection by histone modification
WO2007017065A2 (en) * 2005-07-27 2007-02-15 Oncomethylome Sciences Sa Angiogenesis inhibition based upon icam 1 or junb expression levels
US20080318264A1 (en) * 2005-09-09 2008-12-25 University Of Iowa Research Foundation Biomarkers Associated With Age-Related Macular Degeneration
US20110312897A1 (en) * 2008-09-17 2011-12-22 The Rockefeller University Cathepsin l proteolytically processes histone h3 during mouse embryonic stem cell differentiation
EP2270510A1 (en) 2009-07-02 2011-01-05 EMBL (European Molecular Biology Laboratory) Diagnostic method for predicting the risk of cancer recurrence based on Histone macroH2A isoforms
GB201115098D0 (en) 2011-09-01 2011-10-19 Belgian Volition Sa Method for detecting nucleosomes containing histone variants

Similar Documents

Publication Publication Date Title
JP2017215338A5 (cg-RX-API-DMAC7.html)
JP2014529405A5 (cg-RX-API-DMAC7.html)
RU2014112348A (ru) Способ детекции нуклеосом, содержащих гистоновые варианты
JP2018536849A5 (cg-RX-API-DMAC7.html)
JP2014531573A5 (cg-RX-API-DMAC7.html)
Salzl et al. Evaluation of portal hypertension and varices by acoustic radiation force impulse imaging of the liver compared to transient elastography and AST to platelet ratio index
RU2017126701A (ru) Способ детекции нуклеосом, содержащих нуклеотиды
Rockey Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography
Berzigotti et al. Assessing portal hypertension in liver diseases
Hirano et al. Four-day Bravo pH capsule monitoring with and without proton pump inhibitor therapy
Yuksel et al. An oropharyngeal pH monitoring device to evaluate patients with chronic laryngitis
Shi et al. Normative data of high‐resolution impedance manometry in the C hinese population
Kobak et al. Pulmonary arterial hypertension in patients with primary Sjögren’s syndrome
JP2018529931A5 (cg-RX-API-DMAC7.html)
Zaro et al. Evaluation of the pancreatic tumors by transabdominal shear wave elastography: preliminary results of a pilot study
Reineke et al. Prediction of systolic blood pressure using peripheral pulse palpation in cats
Lippi et al. Diagnostics in venous thromboembolism: from origin to future prospects
Roman et al. Challenges in the swallowing mechanism: nonobstructive dysphagia in the era of high-resolution manometry and impedance
Jones et al. Reflux in idiopathic pulmonary fibrosis: treatment informed by an integrated approach
Imam et al. Impedance nadir values correlate with barium bolus amount
Wu et al. Impedance in the evaluation of the esophagus
Parra‐Moyano et al. Blood and Peritoneal Lactate, Ratio and Difference, and Peritoneal Lactate to Total Solids Ratio for Detection of Intestinal Strangulating Obstructions in Horses
Nunes et al. Pancreatitis-associated protein does not predict disease relapse in inflammatory bowel disease patients
Koch et al. Advances in diagnosing GERD: Which examinations should be performed before interventional therapy?
Kamiya et al. KL‐6 and CEA levels in epithelial lining fluid microsamples predict response to gefitinib in patients with advanced non‐small cell lung cancer